GRIDS Capital

Foundation EGI is a technology company that develops artificial intelligence and large language model (LLM) tools for enterprises in design and manufacturing. Its platform aims to streamline and accelerate all stages of the product development cycle, from design and research to production and documentation. By leveraging LLM, advanced AI, and computer graphics, the company helps engineers enhance product quality, boost productivity, and reduce costs throughout the design and manufacturing process.

Atrandi Biosciences is a privately held biotechnology company that focuses on next-generation single-cell technology, specifically single-cell eukaryotic DNA sequencing. By leveraging proprietary microfluidics technology, Atrandi develops hardware systems, consumables, and software services designed to create user-friendly workflows. This innovative approach facilitates the analysis of genomic alterations and cellular heterogeneity, enabling researchers to effectively study complex biological systems at the single-cell and single-molecule levels.

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.

BigHat Biosciences is a biotechnology company that develops an AI-guided platform for designing and characterizing antibodies and other therapeutic proteins. The platform combines a wet laboratory with artificial intelligence and machine learning to enable antibody discovery and optimization, helping drug developers create antibodies and novel biotherapeutic designs. It emphasizes multi-objective, data-driven workflows to improve safety, biophysical properties, and efficacy of antibody candidates. Founded in 2019 and based in San Carlos, California.

FORT Robotics, Inc. is a company based in Philadelphia, Pennsylvania, that specializes in the development and manufacturing of wireless control systems designed for dangerous machines. The company provides a range of products, including industrial wireless remote control systems, safety devices, and wireless emergency stop systems, which enhance productivity while preventing accidents. FORT Robotics' solutions are utilized in various sectors, such as construction, agriculture, manufacturing, warehousing, transportation, and mobile robotics. By focusing on safety technology, FORT aims to build a comprehensive safety and security platform for smart machines, facilitating the safe integration of automation in industrial applications. The company leverages over a decade of experience to help users and builders of robotic systems accelerate development, mitigate risks, and ensure reliable operation around autonomous systems.

CloudNC is a London-based software company that develops autonomous manufacturing software to automate the programming of computer numerical control milling machines. It provides software and cloud-based services to design tooling paths and streamline CNC programming, enabling factories to produce precision metal components with minimal human intervention. The company also offers an end-to-end manufacturing service intended to replace skilled human roles in metal part production, aiming to improve lead times, machine utilization, and scalability. Incorporated in 2015, CloudNC seeks to modernize manufacturing by making milling processes more efficient and predictable, supporting industries that rely on precision parts.

ALICE Technologies develops an AI-powered construction simulation platform. It uses artificial intelligence to analyze complex building requirements, generate efficient schedules, and optimize them during construction. The platform helps contractors and owners plan, bid, and build more effectively, potentially saving millions in labor costs.

Dusty Robotics, Inc. is a technology company that specializes in automated layout services for the construction industry. Founded in 2018 and headquartered in Mountain View, California, the company has developed the FieldPrinter, a robotic tool that translates digital building information modeling (BIM) designs into accurate, on-site layouts. By integrating BIM information directly onto construction-site floors, Dusty Robotics eliminates manual processes, thereby enhancing efficiency in the construction workflow. The company's innovative solutions serve a diverse clientele, including owners, general contractors, subcontractors, and builders, helping them to reduce labor and material waste and improve the overall design-build-operate lifecycle.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.

Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

CloudNC is a London-based software company that develops autonomous manufacturing software to automate the programming of computer numerical control milling machines. It provides software and cloud-based services to design tooling paths and streamline CNC programming, enabling factories to produce precision metal components with minimal human intervention. The company also offers an end-to-end manufacturing service intended to replace skilled human roles in metal part production, aiming to improve lead times, machine utilization, and scalability. Incorporated in 2015, CloudNC seeks to modernize manufacturing by making milling processes more efficient and predictable, supporting industries that rely on precision parts.

MontyCloud Inc. is a technology company founded in 2018 and based in Woodinville, Washington, that specializes in developing an artificial intelligence-driven SaaS platform for the management and governance of cloud infrastructure, applications, and services. The platform employs an event-driven architecture that leverages AI and machine learning to automate maintenance tasks, monitor cloud services, and provide actionable insights. MontyCloud's solutions encompass various aspects of cloud management, including cost management, security, compliance automation, and disaster recovery, allowing clients to achieve policy-driven, application-centric management across diverse cloud environments.

Ingenuity Foods, Inc.

Endpoint Health, Inc. is a precision immunology company focused on researching and developing therapies that enhance outcomes for patients with critical and immune-driven illnesses, including sepsis, acute respiratory distress syndrome, and COVID-19. Founded in 2018 and headquartered in Palo Alto, California, with additional offices in Detroit, Livonia, and Chicago, the company aims to overcome the limitations of traditional drug development by creating precision therapies tailored to individual patient needs. Utilizing its proprietary AI-powered platform, OMNAI, Endpoint Health identifies and matches high-potential therapies to patients most likely to benefit, ensuring personalized treatment that significantly improves health outcomes. The company is committed to delivering innovative solutions that address the complexities of autoimmune and inflammatory conditions.

Halter Limited, founded in 2016 and based in Morrinsville, New Zealand, specializes in developing GPS-enabled, solar-powered tracking devices for livestock. The company manufactures innovative collars designed for cows, allowing farmers to monitor and guide their animals across pastures. Halter's technology enables virtual fencing, helping farmers optimize productivity while promoting sustainable farming practices. By enhancing the management of livestock, Halter aims to improve agricultural efficiency and animal welfare, contributing to the overall sustainability of pasture-based farming.

Founded in 2018 by Drs. Veronika Stelmakh and Walker Chan, Mesodyne is a pioneering engineering and manufacturing company specializing in innovative electricity generation methods. Their patented LightCell technology converts any fuel to electricity via light, providing rugged, long-lasting, portable power for military and commercial users.

Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

Culture Biosciences, Inc. is a biotechnology company based in South San Francisco, California, that offers an innovative biomanufacturing platform designed for scientists to efficiently run, monitor, and analyze bioreactor experiments through the cloud. Founded in 2016, the company specializes in developing automated bioreactors and fermentation tools that enable biotech companies to optimize their manufacturing processes. By leveraging robotic sample handling and cloud-based data monitoring and analysis, Culture Biosciences significantly accelerates the ability of scientists to manage bioreactor operations compared to traditional methods. This allows for faster product development and market readiness, streamlining the biomanufacturing workflow for its clients.

Syntegra is a company specializing in the generation of synthetic healthcare data that preserves privacy while maintaining the statistical properties of the original data. By employing advanced machine learning techniques, Syntegra creates validated synthetic data derivatives that do not contain any identifiable information, thus addressing the increasing barriers to clinical data access faced by healthcare systems and data aggregators. The company provides an open-access data platform that allows users to conduct analytics, build predictive models, and generate synthetic control groups for clinical trials. Its approach ensures compliance with privacy regulations such as HIPAA and GDPR, with multiple validation methods in place to safeguard data integrity. Syntegra's scalable solution is adaptable to various data types, including images and sensor streams, and is designed to enhance patient care and clinical outcomes. The company is led by a team of experienced entrepreneurs and academics with expertise in medicine and data science.

Fauna Bio develops a cross-mammal drug discovery platform that leverages biology from hibernating and other non-model animals to identify mechanisms that protect against injury and disease. By integrating genomics, transcriptomics, metabolomics, and proteomics across hundreds of species, the company identifies novel drug targets and advances therapeutics for conditions such as heart attack, stroke, neurodegenerative diseases, and other serious human illnesses. Founded by scientists in 2018, it is based in San Francisco. The approach aims to translate natural protective biology into preclinical and early clinical testing to enable recovery from emergency medical conditions.

Heliogen, Inc. is a clean energy company based in Pasadena, California, that specializes in renewable energy technology aimed at replacing fossil fuels in heavy industries. Founded in 2013, Heliogen has developed an AI-enabled, modular concentrated solar system that efficiently harnesses sunlight to produce hydrogen and syngas fuels. Its offerings include HelioMax, a closed-loop control system for electricity generation and process heat; HelioHeat, which provides carbon-free high-temperature heat for sectors such as cement, refining, and mining; and HelioFuel, renewable fuels suitable for transportation, heavy equipment, and residential heating. Heliogen's innovative approach aspires to deliver cost-effective, near 24/7 carbon-free energy at scale, marking a significant advancement in sustainable energy solutions.

Stable provides software solutions designed to assist electric vehicle (EV) fleets and charging providers in efficiently planning and managing their charging infrastructure. Founded in 2016 and based in San Francisco, the company offers a siting and forecasting platform that utilizes a proprietary machine learning model to predict site utilization and optimize the placement and sizing of charging stations. By consolidating essential data and insights, Stable enables customers to make informed decisions regarding the deployment of charging stations, ensuring that they are installed in locations where they are most needed.

Flex Logix Technologies develops embedded FPGA intellectual property cores and software that enable reconfigurable RTL in chip and system designs. Its product suite includes the InferX X1 edge inference co-processor and design tools, supporting embedding programmable logic inside integrated circuits and reconfiguring RTL after manufacture. The company serves aerospace and government customers in the United States and has clients in Israel, China, Europe and other parts of Asia. Founded in 2014 and headquartered in Mountain View, California, Flex Logix also maintains offices in Taipei, Hsinchu, Shanghai and Beijing.

Senti Biosciences is a biotechnology company focused on synthetic biology. It develops gene circuit platforms to engineer therapeutics, with a focus on improving precision and control in cancer treatments.

Momentus offers in-space infrastructure services, including transportation for satellites between orbits, hosted payloads, and in-orbit services. Founded in 2017, the company is based in Santa Clara, California.

nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Dishcraft Robotics, Inc. specializes in developing and manufacturing robotic systems for commercial kitchens, aiming to enhance productivity and reduce waste in the food service industry. The company's innovative technology includes a dishwashing solution that utilizes a rotating scrubber head and advanced computer vision to clean and inspect each dish individually, ensuring thorough sanitation in a fraction of a second. Dishcraft's service, known as Dishcraft Daily, offers comprehensive dishwashing solutions tailored for corporate kitchens and restaurants. Founded in 2015 and based in San Carlos, California, Dishcraft Robotics was previously known as Bistro Technologies, Inc. and rebranded in March 2016.

Matterport is a spatial data company specializing in the digitization and indexing of the built environment. Its comprehensive 3D data platform enables users to create accurate and immersive digital twins of physical spaces. These digital representations can be utilized for various purposes, including design, development, operation, promotion, and analysis of environments. The company generates revenue primarily through subscription fees from customers who access its platform, along with income from licenses, services, and product sales. Matterport's innovative approach facilitates a deeper understanding of spaces, making it a valuable tool for industries such as real estate, architecture, and construction.

ThruWave develops millimeter wave imaging technology for various industries. Founded in 2017, it's headquartered in Seattle, Washington.

Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Instrumental, Inc. specializes in developing software solutions that enhance the efficiency of assembly lines, enabling them to operate autonomously while adapting to various parts and processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to reduce costs associated with scrap and rework by allowing manufacturers to identify and resolve issues on their assembly lines. Instrumental's technology has been deployed in multiple global assembly lines at leading manufacturers, helping to prevent delays in development schedules and start production at higher yields. In addition to its software offerings, Instrumental also provides services related to high-performance computing, data storage, and business continuity, catering to both commercial and government sectors. The firm is headquartered in Saint Paul, Minnesota, and has been operational since 1991.

Founded in Cambridge, Massachusetts in 2019 by Jifei Ou, OPT Industries specializes in precision-engineered products at the micron-scale. Utilizing vertically integrated machinery, software, and design expertise, they provide customers with high-volume production and shortened lead times.

CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.

Plotlogic Pty Ltd is an Australian technology company specializing in ore characterization systems for the mining sector. Based in Brisbane and established in 2005, it employs advanced hyperspectral imaging and AI-driven platforms to enable mine operators to accurately identify the location and material properties of every rock in the mine. Its key products include OreSense LV, which assesses deviations from geological models; OreBlocks, an API for optimizing the planning process; and OreCheck, which delivers real-time alerts to fluctuations in ore quality. The company aims to enhance yield in critical mineral extraction while promoting sustainable mining practices by improving ore recovery, minimizing dilution, and reducing carbon emissions. Plotlogic also offers tailored on-site and off-site support services to ensure effective use of its technologies across various commodities, including coal, iron ore, and gold.

Flex Logix Technologies develops embedded FPGA intellectual property cores and software that enable reconfigurable RTL in chip and system designs. Its product suite includes the InferX X1 edge inference co-processor and design tools, supporting embedding programmable logic inside integrated circuits and reconfiguring RTL after manufacture. The company serves aerospace and government customers in the United States and has clients in Israel, China, Europe and other parts of Asia. Founded in 2014 and headquartered in Mountain View, California, Flex Logix also maintains offices in Taipei, Hsinchu, Shanghai and Beijing.

Momentus offers in-space infrastructure services, including transportation for satellites between orbits, hosted payloads, and in-orbit services. Founded in 2017, the company is based in Santa Clara, California.

Particle Industries, Inc. is a provider of a comprehensive platform designed for the prototyping, scaling, and management of Internet of Things (IoT) products. The company offers a range of hardware development kits, including the Photon for Wi-Fi projects and the Electron for cellular-connected devices, along with various accessories like antennas and USB shields. Particle also delivers software tools such as Tinker, a mobile application for remote control, and Particle Build, a web-based development environment that allows users to write and deploy code easily. Its cloud platform facilitates secure interactions with connected devices through modern APIs, supporting developers in creating intelligent web services. With over 150,000 product builders across more than 170 countries, including notable clients like NASA and SpaceX, Particle has established itself as a key player in the IoT landscape. Founded in 2012 and headquartered in San Francisco, California, with an additional office in Shenzhen, China, the company has been recognized for its innovation and impact in the IoT sector.

Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Optimus Ride is a self-driving vehicle company located in Boston, Massachusetts, focused on developing technologies that promote efficient, sustainable, and equitable mobility systems. As a spinoff from the Massachusetts Institute of Technology, the company leverages over 30 years of interdisciplinary research in self-driving technologies, electric vehicles, and Mobility-on-Demand Systems. Optimus Ride specializes in creating self-driving technology systems tailored for geofenced environments, utilizing innovations in complex sensor fusion, mapping, computer vision, and machine learning. The company's expertise is further enhanced by a team with extensive industrial and entrepreneurial experience in manufacturing robots, urban design, and shared vehicle fleet management, allowing it to offer versatile transportation solutions that range from commercial vessel operations to transit options.

FIGUR8, Inc. is a Boston-based company founded in 2016 as an MIT spin-off, specializing in advanced wearable sensor technology to measure body movement related to musculoskeletal (MSK) conditions. The company's innovative solution integrates smart biosensors, intuitive software, and artificial intelligence to collect and analyze movement data without the need for cumbersome cameras. This technology accurately identifies the sources of MSK pathology, providing essential insights that enhance patient recovery and care management. By enabling trainers, therapists, and physicians to objectively assess musculoskeletal performance, FIGUR8's platform not only improves access to care but also empowers patients to take control of their health. The comprehensive approach records value throughout the entire episode of care, from injury to recovery, ultimately reducing costs and improving health outcomes.

Fauna Bio develops a cross-mammal drug discovery platform that leverages biology from hibernating and other non-model animals to identify mechanisms that protect against injury and disease. By integrating genomics, transcriptomics, metabolomics, and proteomics across hundreds of species, the company identifies novel drug targets and advances therapeutics for conditions such as heart attack, stroke, neurodegenerative diseases, and other serious human illnesses. Founded by scientists in 2018, it is based in San Francisco. The approach aims to translate natural protective biology into preclinical and early clinical testing to enable recovery from emergency medical conditions.

nTopology, Inc. is an engineering software company founded in 2013 and headquartered in New York, New York. The company specializes in developing design software and tools aimed at optimizing manufacturing processes. Its flagship platform, nTopology, empowers engineers to create lightweight and optimized parts that meet specific functional requirements. The software includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, facilitating the integration of geometry and simulation data into manufacturing-ready models. By streamlining workflows and enhancing team collaboration, nTopology serves a diverse range of industries, including aerospace and defense, medical, automotive, consumer products, and education.

Founded in 2016, Nautilus Labs develops a platform that enhances maritime transportation through real-time vessel data analysis. It offers features like TrueVoyage for continuous reporting and ship performance monitoring, serving companies operating various vessel types. The platform aims to improve fleet efficiency and enable predictive decision-making.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that aims to radically improve patients’ lives by decoding biology through the integration of biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company operates a large-scale drug discovery platform built around Recursion OS, an infrastructure layer and a Map of proprietary biological and chemical data, supported by software tools and machine learning to explore biology beyond human bias and identify new therapeutic opportunities. Its platform includes ReChem for selecting and designing compounds, ReScreen and ReScreenRun for planning and automating large-scale experiments, and ReRun, ReAnalyze, and RePredict for digital signatures, data analysis, and predictive modeling of drug relationships. Founded in 2013, the company is based in Salt Lake City, Utah.

Immusoft Corporation is a biotechnology company focused on developing an autologous cell therapy platform aimed at treating a range of human diseases through its proprietary Immune System Programming (ISP) technology. Founded in 2009 and based in Seattle, Washington, Immusoft specializes in modifying the DNA of a patient's immune cells to create biofactories capable of producing gene-encoded medicines, including essential proteins and enzymes that may be missing or defective. The company's innovative approach involves reprogramming B cells, a type of immune cell, which enables them to manufacture and secrete various antibodies. This process not only provides a potential long-term solution for patients but also positions Immusoft at the forefront of biotechnology in addressing rare and infectious diseases.

CytoVale, Inc. is a medical technology company based in San Francisco, California, that specializes in developing innovative biomarkers utilizing the mechanical properties of individual cells, a field known as mechanomics. Founded in 2013, the company employs microfluidics technology to effectively route and physically probe single cells, allowing for the simultaneous measurement of multiple biomarkers. This approach aims to enhance early detection and diagnosis of immune-mediated diseases, particularly sepsis. By leveraging cell mechanics and machine learning, CytoVale seeks to revolutionize the diagnostic landscape, ultimately improving patient outcomes and reducing treatment costs in healthcare.